PetIQ (NASDAQ:PETQ) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.

PETQ has been the topic of several other research reports. Jefferies Group raised PetIQ from a “hold” rating to a “buy” rating and set a $26.00 target price on the stock in a research note on Monday, November 20th. Zacks Investment Research lowered PetIQ from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 12th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $26.83.

PetIQ (PETQ) opened at $22.23 on Wednesday. PetIQ has a one year low of $17.03 and a one year high of $28.23. The company has a debt-to-equity ratio of 0.19, a current ratio of 6.83 and a quick ratio of 4.67.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. American International Group Inc. acquired a new stake in shares of PetIQ during the third quarter worth about $131,000. Keeler Thomas Management LLC acquired a new stake in shares of PetIQ during the fourth quarter worth about $131,000. Wells Fargo & Company MN acquired a new stake in shares of PetIQ during the third quarter worth about $204,000. Geode Capital Management LLC raised its position in shares of PetIQ by 16.5% during the fourth quarter. Geode Capital Management LLC now owns 60,143 shares of the company’s stock worth $1,313,000 after purchasing an additional 8,512 shares during the period. Finally, Penn Capital Management Co. Inc. raised its position in shares of PetIQ by 18.0% during the fourth quarter. Penn Capital Management Co. Inc. now owns 70,123 shares of the company’s stock worth $1,531,000 after purchasing an additional 10,697 shares during the period. 56.57% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & international copyright & trademark law. The legal version of this news story can be viewed at https://theolympiareport.com/2018/02/14/bidaskclub-lowers-petiq-petq-to-hold.html.

About PetIQ

PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.

Analyst Recommendations for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.